This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
5/28/2026
Good afternoon, ladies and gentlemen, and welcome to Perimeter Medical Q1 2026 conference call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, May 28, 2026. I would now like to turn the conference over to Stephen Kilmer, Investor Relations. Please go ahead.
Thank you. Good afternoon, everyone. Let me start by pointing out that this conference call will include forward-looking statements within the meaning of applicable securities laws. These may include statements regarding the future financial position, business strategy and strategic goals, commercial activities and timing, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, The potential benefits of our products, including Perimeter S Series, OCT, and CLAIRE, formerly Perimeter B Series, OCT, Perimeter's ability to broaden its user base and system utilization, expectations regarding new products and the timing thereof, and expectations regarding opportunities for market expansion. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond our control, including the risks and uncertainties described from time to time in our public filings and press releases, which are posted on CDER+. Our results may differ materially from those projected on today's call. No forward-looking statement can be guaranteed. Perimeter undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, other than what is required by law. On the call, representatives of the company are Adrian Mendez, Perimeter's Chief Executive Officer, Sarah Bryan, the company's Chief Financial Officer, Abby Goodman, Perimeter's VP of Sales, and Andrew Berkley, Perimeter's chief innovation officer and co-founder.
With that said, I'll turn the call over to Sarah.
You're reading a preview of the PINK Q1 2026 earnings call.
Free account.
